Table 1.
Age (years) | 62 (40–77) |
Male gender (%) | 28 (80) |
Etiology, n (%) | |
− HBV* | 8 (22.9) |
− HCV** | 16 (45.7) |
− Alcohol | 7 (20.0) |
− NASH/cryptogenic | 4 (11.4) |
Laboratory tests | |
− AST (U/L) | 47.5 (11–268) |
− ALT (U/L) | 37 (7–217) |
− Total bilirubin (mg/dl) | 0.7 (0.4–27.7) |
− Albumin (g/L) | 41 (22–49) |
− AFP (ng/ml) | 10.35 (2–250) |
− CA 19-9 (U/L) | 41.5 (1–4920) |
Tumor characteristics | |
− Nodule size (mm) | 25 (10–100) |
− Within Milan Criteria (%) | 21 (60) |
− Macrovascular invasion/ extrahepatic spread (%) | 7 (20) |
*Three patients had an HBV/HCV co-infection; **two patients had a concurrent alcohol abuse.
HBV: hepatitis B virus; HCV: hepatitis C virus; NASH: non-alcoholic steatohepatitis; AST: aspartate aminotransferase; ALT: alanine aminotransferase; AFP: alfa-fetoprotein.